Pillstats
Rx only · Tablet, Film Coated · Oral

Colestipol Hydrochloride

Colestipol Hydrochloride

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)2685
US makers6 labelers
Packages9
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.197$0.393$0.590$0.786Dec 2025Apr 2026Jul 2026
$0.670
Latest avg · Jul 22, 2026
-1%
Since Dec 17, 2025
6
Active US suppliers
44%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

10K20K30K40K2025 Q12025 Q22025 Q32025 Q42026 Q1
29K
Rx · 2026 Q1
2.9M
Units dispensed
-5%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Zydus Lifesciences Limitedunknown2SUPPLYING
Amneal Pharmaceuticals of New York LLCunknown2SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown2SUPPLYING
ANI Pharmaceuticals, Inc.unknown1SUPPLYING
Ingenus Pharmaceuticals, LLCunknown1SUPPLYING
American Health Packagingunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.